Artificial intelligence helps detect prostate cancer at an early stage and reduce the number of false negative results

He prostate cancer This is one of the most common types in men, and fortunately, if caught early, it can be treated more effectively. In the early stages, prostate cancer often has no symptoms.

To detect this tumor at an early stage, it is necessary to do a blood test to measure prostate specific antigen (PSA) levels. If there is a high PSA level, a magnetic resonance imaging (MRI) of the prostate should be done, and if the MRI shows any damage, a biopsy should be done.

As he explained to us Dr. Kai VilanovaRadiologist and Director of the Magnetic Resonance Unit at the Girona Clinic, “the usual treatment for prostate cancer is surgery or radiotherapy. Currently, there are new modern treatment methods that allow the tumor to be treated focally. There is a type of prostate cancer that is rarely aggressive and does not need to be treated, but should be monitored annually to confirm that it is not an aggressive tumor.

The importance of early detection of prostate cancer

The overall 5-year survival rate for prostate cancer is 90%, and in low-aggressive tumors and may be 30-40% in cases of tumor metastasis depending on age and response to treatment. However, in recent years, artificial intelligence has played a key role.

An important tool for detecting prostate cancer is MRI, which is an equivalent test to mammography for breast cancer.

Prostate MRI provides detailed information about the prostate gland, requiring a radiologist to spend time analyzing the test to identify possible areas of suspicion for tumor.

“Eat Artificial Intelligence Tools available as QP-Prostate, which allows prostate MRI analysis to detect cancer in the early stages, significantly improving the prognosis and treatment of the disease,” says the specialist.

Benefits of incorporating AI into standard MRI techniques:

• improve the quality and speed of image acquisition
• better accuracy
• faster scan report and diagnostic efficiency

AI is a tool that “enables improved clinical outcomes and optimization of medical resources. Its careful integration and ongoing validation promises a significant positive impact on prostate cancer treatment by increasing diagnostic confidence.”

AI against false positives in this tumor type

It is a “transformative” tool for reduce false-positive and false-negative results in the diagnosis of prostate cancer.

“According to a study conducted in the US, compared to 79.8% of radiologists when they do not have this artificial intelligence tool. Its ability to analyze complex data, provide objective analysis, and integrate clinical information with imaging data leads to more accurate diagnoses and more effective patient management.

Moreover, “through gradual integration into medical practice, AI promises to improve clinical outcomes and reduce emotional and economic burden associated with misdiagnosis.

Stigma against prostate cancer still exists

Stigma around prostate cancer and men’s health In general, it has roots in cultural, social and psychological factors, Dr. Vilanova emphasizes.

“Eat lack of awareness about the importance of early diagnosis, fear of cancer and its adverse consequences; and difficulty accessing the health care system, with possible delays in seeking care, which can negatively impact men’s health.

Gender roles “significantly” influence some men’s reluctance to seek medical help, as “social and cultural norms associated with masculinity can create psychological and behavioral barriers.”

The radiologist clarifies that “there may be certain taboo regarding the prostate as an organ associated with male sexuality and masculinity. “Some men may be reluctant to seek medical help, perpetuating the cycle of late diagnoses and worse health outcomes.”